| |
 |
|
Class Information
Number: 424/185.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same
Description: Subject matter wherein an amino acid sequence specifying an antigen, an epitope, or another immunospecific immunoeffector is disclosed in whole or in part, wherein the disclosed amino acid sequence may be part of a conjugate, a complex, or a fusion protein or fusion polypeptide.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7108854 |
Surface proteins of Leptospira |
Sep. 19, 2006 |
| 7108853 |
Surface protein of Leptospira |
Sep. 19, 2006 |
| 7105162 |
Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
Sep. 12, 2006 |
| 7105163 |
Mite protein |
Sep. 12, 2006 |
| 7105170 |
Latent human tuberculosis model, diagnostic antigens, and methods of use |
Sep. 12, 2006 |
| 7107092 |
Methods for diagnosing a neurodegenerative condition |
Sep. 12, 2006 |
| 7101555 |
Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis |
Sep. 5, 2006 |
| 7101556 |
Preparation and usage of plasmodium fusion antigen |
Sep. 5, 2006 |
| 7101557 |
Combined tissue factor methods for coagulation and tumor treatment |
Sep. 5, 2006 |
| 7097841 |
Ferritin fusion proteins for use in vaccines and other applications |
Aug. 29, 2006 |
| 7098303 |
Conserved motif of hepatitis C virus E2/NS1 region |
Aug. 29, 2006 |
| 7098306 |
Method and compositions for treating hepatocellular cancer |
Aug. 29, 2006 |
| 7094396 |
Method for making cytokine specific antibodies and uses thereof |
Aug. 22, 2006 |
| 7094409 |
Antigen arrays for treatment of allergic eosinophilic diseases |
Aug. 22, 2006 |
| 7094410 |
DNA vaccine against proliferating endothelial cells and methods of use thereof |
Aug. 22, 2006 |
| 7094411 |
Avirulent, immunogenic flavivirus chimeras |
Aug. 22, 2006 |
| 7094874 |
Soluble CTLA4 mutant molecules |
Aug. 22, 2006 |
| 7090849 |
Babesia canis vaccine |
Aug. 15, 2006 |
| 7090850 |
Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
Aug. 15, 2006 |
| 7091181 |
Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
Aug. 15, 2006 |
| 7087230 |
Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
Aug. 8, 2006 |
| 7087231 |
Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
Aug. 8, 2006 |
| 7087235 |
Fusion protein of streptococcal pyrogenic exotoxins |
Aug. 8, 2006 |
| 7087717 |
Sp110, a polypeptide component of the nuclear body |
Aug. 8, 2006 |
| 7083788 |
Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
Aug. 1, 2006 |
| 7083789 |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
Aug. 1, 2006 |
| 7083790 |
Extracellular serine protease |
Aug. 1, 2006 |
| 7083791 |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
Aug. 1, 2006 |
| 7083792 |
Immunologically active proteins from Borrelia burgdorferi |
Aug. 1, 2006 |
| 7083796 |
Fusion proteins of mycobacterium tuberculosis |
Aug. 1, 2006 |
| 7083797 |
32-kDa protein derived from Mycobacterium tuberculosis and related peptides |
Aug. 1, 2006 |
| 7083959 |
Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
Aug. 1, 2006 |
| 7084239 |
Cancer peptides of NY-ESO-1/CAG-3 |
Aug. 1, 2006 |
| 7084247 |
Identification of self and non-self antigens implicated in autoimmune diseases |
Aug. 1, 2006 |
| 7078037 |
Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections |
Jul. 18, 2006 |
| 7078043 |
Malaria vaccine |
Jul. 18, 2006 |
| 7074408 |
Use of integrin antagonists to inhibit angiogenesis |
Jul. 11, 2006 |
| 7074409 |
Polypeptides having a triggering NK activity and biological applications |
Jul. 11, 2006 |
| 7074410 |
Modified HCV peptide vaccines |
Jul. 11, 2006 |
| 7074620 |
Controlling protein levels in eucaryotic organisms |
Jul. 11, 2006 |
| 7074889 |
Identification of a new cytotoxic activity from the ink of Aplysia punctata |
Jul. 11, 2006 |
| 7074896 |
Recombinant soluble Fc receptors |
Jul. 11, 2006 |
| 7074900 |
Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
Jul. 11, 2006 |
| 7070774 |
Antibodies that bind testis-specific insulin homolog polypeptides |
Jul. 4, 2006 |
| 7070779 |
POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM |
Jul. 4, 2006 |
| 7070780 |
Treatment of demyelinating autoimmune disease with ordered peptides |
Jul. 4, 2006 |
| 7070782 |
Prostate-specific membrane antigen |
Jul. 4, 2006 |
| 7070783 |
Small molecular weight TNF receptor multimeric molecule |
Jul. 4, 2006 |
| 7070784 |
Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues |
Jul. 4, 2006 |
| 7070785 |
Heat shock proteins for use in enhancing cellular factor production |
Jul. 4, 2006 |
|
|
|
